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ABSTRACT 
Lipopolysaccharide (LPS) is a main causative agent of septic shock. In this study we investigated the possible effects of Rutin (RT) 
against LPS-induced endotoxemia model in vivo to determine whether RT could rescue mice from ensuing death after their exposure 
to LPS. To further understand the role of RT, the responses of cytokines were also assessed in serum isolated from blood collected at 0, 
1.5, 3, 6, and 12h after LPS administration of the mice. In the study, RT showed suppressive effects on TNF-α, IL-6, and IL-1β 
production by LPS- challenged mice. Furthermore, RT protected mice by improving host survival against LPS challenge. The present 
ﬁndings reinforce the potential of RT, a natural compound as drug candidate for prevention of sepsis progression. 
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INTRODUCTION  
Inflammation is a localized protective response elicited 
by injury or destruction of tissues that serves to destroy, 
dilute, or sequester the injurious agent and injured tissue. 
Sepsis is considered a systemic inflammatory disorder 
and a serious clinical problem with a high mortality. The 
acute-phase response is a major pathophysiological 
phenomenon that accompanies inflammation and is 
associated with increased activity of pro-inflammatory 
cytokines 
1
. Bacterial LPS, a constituent of the cell wall of 
Gram-negative bacteria, is a major causative agent of 
septic shock. In experimental animals, LPS challenge 
leads to pathophysiological changes similar to the human 
septic shock syndrome. The presence of apoptotic cells 
during monocyte activation with LPS decreases secretion 
of the proinﬂammatory cytokines TNF-α, IL-1, and IL-12 
2
. Major cytokines that participate in the inflammatory 
response after LPS administration include tumor necrosis 
factor (TNF)-α, as well as interleukin (IL)-1, -2, -6, and -8 
3
. The TLR4 family plays a central role in activation of 
innate immune system. LPS is thought to bind directly to 
TLR4, and it initiates the transmembrane signaling via an 
adaptor protein MyD88, leads to activation of NF- KB, 
and induces a number of inﬂammatory mediators 4.  
Rutin (RT) (figure 1), a citrus flavonoid found in a wide 
variety of plants including citrus fruit 
5
, buckwheat 
6
 is 
known to possess antioxidant properties 
7
 by effectively 
reducing ferryl intermediate back to ferric Hb at 
physiological pH. It exhibited more protective effect on 
H2O2-induced Hb oxidation 
8
. Furthermore, rutin 
increased skin elasticity and decreased the length, area 
and number of wrinkles 
7
. A number of studies have 
shown that RT relieves swelling, aching, and pain from 
varicose veins.  Because RT strengthens arteries and 
veins, it is also used to help treat hemorrhoids, internal 
bleeding, and to help prevent hemorrhagic strokes. 
Scientists found that RT inhibited the enzyme Coll2-1, a 
marker for osteoarthritis 
9
. Its use is advantageous over 
other flavonoids as it is a nontoxic and nonoxidizable 
molecule. Although research has shown its multispectrum 
pharmacological benefits for the treatment of various 
chronic diseases such as cancer, diabetes, hypertension 
and hypercholesterolemia 
10
, little progress was done 
about its antiinﬂammatory effects on septic shock. It has 
been known that any means to regulate an excessive 
systemic inflammatory response would be a promising 
and beneficial strategy leading to a mitigation of 
endotoxic sepsis. Therefore, in this study, we evaluated 
the effects of RT against lethal endotoxemia in mice.  
 
Figure 1: The chemical structure of Rutin 
MATERIALS AND METHODS  
Chemical and reagents 
Rutin (purity 98.7%) was purchased from the Sichuan 
Tongtai Botanical Chemical Industry Co., Ltd. Dimethyl 
sulfoxide (DMSO) and lipopolysaccharide (LPS, 
Escherichia coli 055:B5) were purchased from Sigma 
Chemical Co. (San Diego, CA, USA). (TNF)-α, IL-1β, 
and IL-6 ELISA kits were purchased from Biolegend (San 
Diego, CA). 
2.2. Animals 
BALB/c male mice, 8 weeks old and weighing 
approximately 18 to 20 g, were maintained at an animal 
facility under pathogen free conditions. The mice were 
fed a standard diet and water ad libitum and housed in 
microisolator cages under standard conditions 
(temperature: 24 ± 1 °C, relative humidity: 40%–80%). 
The mice were allowed to adapt themselves to their 
environment for 2–3 days before experimentation. 
Induction of shock and treatment regimen  
To select a suitable concentration of LPS for inducing 
shock, 48 mice were divided into four groups 
(n=12/group) and challenged with LPS (5–40 mg/kg) via 
a single intraperitoneal (IP) injection. The mice were 
observed for mortality twice a day for 7 days, and survival 
rates were recorded. 
Mice were treated with RT at different doses (60, 80 or 
100 mg/kg), or vehicle (5% of DMSO in saline), by the 
intraperitoneal (i.p.) route. One hour later, animals were 
challenged with LPS (20 mg/kg). The mice were 
randomly divided into five groups, i.e. control (vehicle), 
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LPS (20 mg/kg) only, and RT (60, 80, or 100 mg/kg) + 
LPS. 
Measurement of cytokines concentrations 
At 0, 1.5, 3, 6, and 12h after administration of the LPS, 
blood was recovered from the tail vein of each mouse and 
serum isolated; the serum was stored at -70
o
C. TNF-α, 
IL-6, and IL-1 concentrations in serum samples were 
determined by enzyme-linked immunosorbent assay 
(ELISA), using the DuoSet kit from R&D Systems 
(Minneapolis, MN). 
Statistical analysis 
Results are presented as means ± SEM. Differences 
between mean values of normally distributed data were 
assessed with one-way ANOVA (Dunnett's t-test) and 
two-tailed Student's t-test. Statistical significance was 
accepted at P<0.05 or P<0.01. 
RESULTS  
Effect of RT on LPS-induced mortality  
To evaluate the protective relevance of RT, we examined 
its effect on LPS-induced mortality in mice. After LPS 
challenge, mice showed signs of severe sepsis such as 
decreased activity, conjunctivitis, diarrhea, lethargy, 
piloerection, huddling, etc. Overall, mice that were 
injected with ip 40 mg/kg LPS survived until 12 hours. 
However, in groups of mice given 5, 10, or 20 mg LPS/kg, 
the mortality rates were, respectively, 5, 15, and 78% 
(Figure 2). Therefore, the concentration of 20mg LPS/kg 
was chosen as a lethal dose that induced septic shock. In 
the subsequent experiments here, mice were injected with 
the 20mg LPS/kg. 
 
Figure 2: Effects of different doses of LPS in a mouse 
model of sepsis. The mice were divided into four groups 
(n=12/group) and challenged with LPS (5–40 mg/kg) via 
a single intraperitoneal (IP) injection. The mice were 
observed for mortality twice a day for 7 days, and survival 
rates were recorded.  
 
Figure 3. Effect of administration of Rutin (RT) on 
LPS-induced sepsis in mice. Mice were divided into five 
groups (control, LPS (20 mg/kg) only, and LPS (20 mg/kg) 
+ 3 treatment groups of RT) (n= 12/group). **p<0.01 
versus LPS-only group. 
The pathophysiology of sepsis is supposed to be 
associated with a devastating or excessive host response 
involving dysregulated inﬂammation. Septic shock 
induced organ hypoperfusion, which progresses to 
multiple organ dysfunctions; this is clinically 
characterized by liver, pulmonary, cardiovascular, renal, 
and gastrointestinal dysfunction 
11
. To assess the potential 
effect of RT against endotoxin-mediated mortality, its 
effect on mortality in mice with lethal endotoxemia was 
monitored. As shown in Figure 3, pre-treatment with RT 
significantly reduced LPS-induced mortality in mice. 
Taking the lower dose of RT (60 mg/kg) showed 46 
percent protection. However, the doses of RT (80 or 100 
mg/kg) rescue mice from lethal experimental sepsis, 56 
and 84%, respectively (figure 3). These results support 
the hypothesis that RT provides a survival advantage in 
the presence of LPS-induced endotoxemia. 
Effect of RT on LPS-induced cytokine responses in 
vivo 
Several studies showed that the inflammatory mediators 
help the innate immune response but their overproduction 
results in acute phase endotoxemia that causing tissue 
injury, organ failure, shock, and even death 
12,13,14
. The 
discovery of new agents capable of down-modulating the 
production of the inﬂammatory mediators that play key 
roles in the installation of sepsis is therefore of great 
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interest for the development of effective treatments. To 
assess the effects of RT, the levels of pro-inflammatory 
cytokines mechanistically linked to endotoxemia were 
measured in blood samples collected from mice 0, 1.5, 3, 
6, and 12 h after LPS challenge. As results, levels of 
TNF-α, IL-1b, and IL-6 production in RT-pre-treated (100 
mg/Kg), LPS-challenged mice (20mg/Kg) were 
consistently decreased as compared to that in mice that 
received the LPS alone (figure 4). The results from this 
investigation provide novel in vivo evidence showing that 
pretreatment with RT signiﬁcantly regulated the 
overproduction of TNF-α, interleukin IL-1, IL-6. 
 
 
 
Figure 4: Effects of Rutin (RT) on the levels of 
pro-inflammatory cytokines mechanistically linked to 
endotoxemia. Mice were injected IP with RT 1 h before 
challenge with the LPS (20 mg/kg) and the blood samples 
were collected from mice 0, 1.5, 3, 6, and 12 h after LPS 
challenge. The serum levels of inflammatory cytokines 
were measured using ELISA. **p<0.01 versus LPS-only 
group. 
DISCUSSION  
Rutin (RT), a citrus flavonoid is known to possess 
multispectrum pharmacological benefits. The current 
study is the ﬁrst to demonstrate that administration of RT 
can protect mice from LPS-induced death. The promising 
effects of RT administration included i) prevented 
mortality in mice injected with a lethal dose of LPS, ii) 
reduced host-derived proinflammatory cytokines.  
LPS, a major cell wall component of gram-negative 
bacterial organisms; it mediates many of the 
pathophysiologic events in sepsis by stimulating the 
release of circulating proinﬂammatory cytokines. The 
sepsis syndrome is an acute systemic illness characterized 
by  shock,  coagulopathy,  and  multiorgan  
dysfunction,  with death  occurring  in  as  many  as  
25–35%  of  patients  with  this syndrome 12, 15.  
Several studies showed that the pathogenesis of lethal 
sepsis remains obscure, but is associated with 
dysregulated production of inflammatory mediators. The 
early events of severe sepsis set in motion a cascade of 
events that contributes to the morbidity and mortality 
observed during the first few days of this syndrome 
16, 17
. 
Specifically, when compared with control group, we 
observed a significant increase in endotoxin-induced 
mortality in animals treated with LPS. Furthermore, the 
pre-administration of RT (80 mg/kg or 100 mg/kg) 
provided substantial protection via preventing, not only, 
the development of clinical manifestations of LPS 
administration (decreased activity, lethargy, diarrhea, 
piloerection, huddling), but also, the mortality against the 
lethal effects of LPS. 
Macrophage activation by LPS results in the release of 
several inﬂammatory mediators, including 
proinﬂammatory cytokines such as tumor necrosis factor 
(TNF)-α, interleukin (IL)-1, IL-6, IL-8, and IL-12. The 
exacerbated productions of these mediators by activated 
macrophages are the main cause of the consequences of 
septicemia, and may lead to disseminated intravascular 
coagulation, hypotension, tissue hypoxia, death and 
neutrophil extravasation to tissues 
18, 19, 20
. (TNF)-α can 
induce vascular endothelial cells to express adhesion 
molecules, stimulating migration of PMNs, and therefore 
mediate the inﬂammatory changes in the multiple organs, 
resulting in PMN-dependent organ damage. It is shown 
that (TNF)-α may play a role in the progression of 
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multiple organ failure in septic shock, and there is an 
association between (TNF)-α and severity of shock and 
mortality 
21, 22
.The study demonstrated the in vivo 
protective effects of RT on production of these 
pro-inflammatory cytokines in LPS-challenged mice. 
NF-KB is required for maximal transcription of numerous 
cytokines, including tumor necrosis factor a (TNF-a), 
interleukin 1b (IL-1b), and interleukin 6 (IL-6); notably 
they participated in the early development of 
inflammation. (TNF)-α is the earliest and primary 
endogenous mediator of the process of an inflammatory 
reaction that can elicit the inflammatory cascade and 
cause damage to the vascular endothelial cells. TNF-a can 
also induce alveolar epithelial cells to produce other 
cellular factors and chemotactic, such as IL-6. IL-6 is one 
of the most common inflammatory cytokines 
23, 24, 25
. IL-1 
is a multifunctional cytokine that is responsible for 
various processes including host defense, inflammation, 
and response to injury. Many types of cells 
(predominantly macrophages) produce IL-1 after 
stimulation with viruses or bacterial components 
26
. 
Therefore, inhibition of these proinflammatory mediators 
is a key issue in preventing endotoxic shock. In this 
experiment, we found that pretreatment with RT can 
effectively inhibit the production of TNF-a, IL- 1b and 
IL-6 in LPS-induced endotoxemia suggesting that RT 
could be a promising agent to prevent inflammatory 
diseases. As shown here, these findings indicate that the 
protective role of RT in endotoxemia may be attributable, 
at least in part, to modulation of pro-inflammatory 
cytokine production. The statement is consistent with the 
hypothesis that inflammation process can be mediated by 
pro-inflammatory mediators, including tumor necrosis 
factor (TNF)-α, interleukin (IL)-1, IL-6, interferon 
(IFN)-γ, IL-12, IL-18, nitric oxide, and cell adhesion 
molecules. Inflammation and depression are closely 
inter-related; inflammation induces symptoms of 
depression and, conversely, depressed mood and stress 
favor an inflammatory phenotype. Anxiety 
and depression often appear together in the clinical 
population, as well as, fever, lethargy, hypophagia, 
anhedonia and impaired cognitive function 
27
. The results 
found here may have a non-negligible effect when 
considering the consequences of the inflammatory 
mediators in mice.  
CONCLUSION  
In conclusion, this study provides evidence for the in vivo 
effects of RT on lipopolysaccharide-induced endotoxemia. 
This observation may be in future study a rationale for 
exploring the therapeutic potential of RT against other 
inflammatory pathologies.
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